Comprehensive geriatric care for patients with hip fractures: a prospective, randomised, controlled trial A Prestmo, G Hagen, O Sletvold, JL Helbostad, P Thingstad, K Taraldsen, ... The Lancet 385 (9978), 1623-1633, 2015 | 622 | 2015 |
Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010 T Wisløff, G Hagen, V Hamidi, E Movik, M Klemp, JA Olsen Pharmacoeconomics 32, 367-375, 2014 | 191 | 2014 |
Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation T Wisløff, G Hagen, M Klemp Pharmacoeconomics 32, 601-612, 2014 | 67 | 2014 |
Estimating the future burden of hip fractures in Norway. A NOREPOS study G Hagen, J Magnussen, G Tell, T Omsland Bone 131, 115156, 2020 | 42 | 2020 |
New anticoagulants as thromboprophylaxis after total hip or knee replacement V Hamidi, T Ringerike, G Hagen, Å Reikvam, M Klemp International journal of technology assessment in health care 29 (3), 234-243, 2013 | 24 | 2013 |
Effect of a fracture liaison service on the rate of subsequent fracture among patients with a fragility fracture in the Norwegian capture the fracture initiative (NoFRACT): a … C Andreasen, LB Solberg, T Basso, TT Borgen, C Dahl, T Wisløff, ... JAMA Network Open 1 (8), e185701-e185701, 2018 | 19 | 2018 |
Effectiveness of Task Specific Gait and Balance Exercise 4 Months After Hip Fracture: Protocol of a Randomized Controlled Trial—The Eva‐Hip Study P Thingstad, K Taraldsen, G Hagen, S Sand, I Saltvedt, O Sletvold, ... Physiotherapy Research International 20 (2), 87-99, 2015 | 18 | 2015 |
Cost-effectiveness of varenicline, bupropion and nicotine replacement therapy for smoking cessation G Hagen, T Wisløff, M Klemp Rapport fra Kunnskapssenteret, 2010 | 15 | 2010 |
Tidlig ultralyd i svangerskapsomsorgen V Lauvrak, IN Norderhaug, G Hagen, E Movik, G Acharya, A Forus, ... Folkehelseinstituttet, 2012 | 12 | 2012 |
Unfallchirurgisch-geriatrisches Co-Management in der Alterstraumatologie B Bücking, U Liener, C Bliemel, S Ruchholtz Orthopädie und Unfallchirurgie up2date 13 (04), 343-356, 2018 | 10 | 2018 |
Kostnadseffektivitet av å inkludere vaksinasjon mot rotavirus i det norske barnevaksinasjonsprogrammet K Samdal, G Hagen, E Flem, M Klemp Norwegian Knowledge Centre for the Health Services, 2009 | 9 | 2009 |
Efficacy and cost-effectiveness of alendronate for the prevention of fractures in postmenopausal women in Norway G Hagen, T Wisløff, J Falch, C Lofthus, F Frihagen, KA Wensaas, ... | 8 | 2017 |
The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention—the impact of cardiovascular effects G Hagen, T Wisløff, IS Kristiansen Osteoporosis international 27, 2089-2098, 2016 | 7 | 2016 |
Efficacy and cost-effectiveness of new oral anticoagulants compared to warfarin for the prevention of stroke in patients with atrial fibrillation T Wisløff, T Ringerike, G Hagen, Å Reikvam, M Klemp Rapport fra Kunnskapssenteret, 2013 | 6 | 2013 |
Helseøkonomisk evaluering ved Nasjonalt kunnskapssenter for helsetjenesten G Hagen, T Wisløff, M Klemp Norsk epidemiologi 23 (2), 2013 | 5 | 2013 |
Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip-or knee replacement surgery T Ringerike, V Hamidi, G Hagen, Å Reikvam, M Klemp Norwegian Knowledge Centre for the Health Services, 2011 | 5 | 2011 |
Validation of forearm fracture diagnoses in administrative patient registers TK Omsland, LB Solberg, Å Bjørnerem, TT Borgen, C Andreasen, ... Archives of Osteoporosis 18 (1), 111, 2023 | 4 | 2023 |
Registry data for use in health technology assessments in Norway-Oppourtunities and challenges G Hagen, T Wisløff NTNU Open Access Journals, 2021 | 4 | 2021 |
Cost-effectiveness of childhood vaccination against rotavirus in Norway K Samdal, G Hagen, E Flem, M Klemp | 4 | 2018 |
Legemidler til røykeslutt IM Sæterdal, T Ringerike, J Odgaard-Jensen, I Harboe, G Hagen, ... Norwegian Knowledge Centre for the Health Services, 2010 | 4 | 2010 |